Skip to content

HYMOVIS High Molecular Weight Viscoelastic Hyaluronan

by Fidia Farmaceutici

PMA P150010

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

PMA P150010↗

FDA record

Trust

Unverified

Source FDA PMA, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP150010 Date28 Aug 2015ApprovedStatusActive

Official records

From the FDA record

FDA PMA P150010

Received by the FDA
25 Feb 2015
FDA decision
28 Aug 2015
FDA review time
184 days from receipt to decision
Docket number
15M-3256
Approval order statement, verbatim
APPROVAL FOR HYMOVIS. THIS DEVICE IS INDICATED FOR THE TREATMENT OF PAIN IN OSTEOARTHRITIS (OA) OF THE KNEE IN PATIENTS WHO HAVE FAILED TO RESPOND ADEQUATELY TO CONSERVATIVE NON-PHARMACOLOGIC THERAPY AND TO SIMPLE ANALGESICS (E.G., ACETAMINOPHEN).

From the FDA PMA record P150010 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Trade name
Hymovis
Generic name
Acid, hyaluronic, intraarticular
PMA number
FDA product code
MOZ
Device class
Class III
Advisory committee
Orthopedic
FDA decision
APPR Approved

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

Hymovis is an intraarticular acid hyaluronic device classified as a Class III medical product. It is formulated as a high molecular weight viscoelastic hyaluronan designed to restore synovial fluid properties in osteoarthritic joints, providing lubrication and cushioning to alleviate joint pain and improve mobility.

The device is supplied as a sterile, single-use injectable solution intended for intraarticular administration in patients with knee osteoarthritis unresponsive to conservative therapies. It is regulated under FDA PMA approval (P150010) and distributed in pre-filled syringes, requiring refrigeration prior to use. Compliance with FDA guidelines ensures its safety and efficacy for intraarticular use, with no MRI safety restrictions specified.

Devices cleared under P150010

7 devices · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under P150010
UDI-DISize and differences
Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe 89122-0496-63
Fidia Farmaceutici
89122-0496-63 / 89122-0496-63M71389122049663A16
Total Volume 3 mL
No longer on the market
Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe 89122-4966-30
Fidia Farmaceutici
89122-4966-30 / 89122-4966-30M71389122496630A16
Total Volume 3 mL
No longer on the market
Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe FID185704
Fidia Farmaceutici
FID185704 / FID185704M71389122496630SAM1
Total Volume 3 mL
No longer on the market
Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe FID185704
Fidia Farmaceutici
FID185704 / FID185704M71389122049663SAM1
Total Volume 3 mL
No longer on the market
Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe, 1 pack 89122-0496-01
Fidia Farmaceutici
89122-0496-01 / 89122-0496-01M713891220496010
Total Volume 3 mL
On the market
HYMOVIS® ONE 32mg/4ml syringe 89122-0750-01
Fidia Farmaceutici
89122-0750-01 / 89122-0750-01M713891220750010
Total Volume 3 mL
On the market
HYMOVIS® ONE Professional Sample, 32mg/4ml syringe FID07501
Fidia Farmaceutici
FID07501 / FID07501M713FID075010
Total Volume 3 mL
On the market

Similar devices

Other devices filed under FDA product code MOZ (Acid, Hyaluronic, Intraarticular).

Other devices from Fidia Farmaceutici

See all devices from Fidia Farmaceutici →